Regions with high death rates are often called high cancer burden areas. For the past 20 years, for all cancers combined and for several of the most common types of cancer the cancer burden areas have ...
Vitamin B12 has long been seen as a health hero, helping the body make red blood cells, repair DNA, and keep nerves ...
When Amy Dowden signed up for the new series of Who Do You Think You Are?, she hoped to solve rumours of a murder, confirm that she was 100 per cent Welsh and discover whether any of her ancestors ...
Research shows that considering how we will be remembered when we die can help us improve our mental health and find more ...
A small study found a surprisingly high incidence of precancerous polyps in young, extreme runners, sparking controversy and ...
Although many younger adults diagnosed with colorectal cancer may not initially believe they are at risk, Lee Kong stressed ...
Colon cancer is the leading cause of cancer deaths in people under the age of 50, according to the American Cancer Society, but what's behind the alarming surge and why are cases shifting? The issue ...
Cancer screening can feel like a rite of passage as we get older: skin cancer checks in your late 30s, a mammogram at age 40, a colonoscopy at age 45. However, as young cancer cases have skyrocketed, ...
Former Senator Ben Sasse speaks about his pancreatic cancer diagnosis and his experience with experimental cancer drugs, the challenges of reforming higher education, the dysfunction in the Senate, ...
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients? By Simar Bajaj More than half of patients with metastatic lung cancer don’t receive ...
Incidence in women <50 is now 82% higher than in men, representing a 51% increase versus 2002, suggesting biologic change rather than improved detection alone. Rising rates appear concentrated in ...
For patients whose skin cancer doesn’t respond to traditional treatments, a new drug called RP1 has been a lifeline—at least for those who can get into a clinical trial. The drug has shown so much ...